Search Results - "Holmatov, Maxim M."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation by Moiseyenko, Fedor V., Egorenkov, Vitaliy V., Kramchaninov, Mikhail M., Artemieva, Elizaveta V., Aleksakhina, Svetlana N., Holmatov, Maxim M., Moiseyenko, Vladimir M., Imyanitov, Evgeny N.

    Published in Case reports in oncology (01-05-2019)
    “…Vemurafenib has been developed to target common BRAF mutation V600E. It also exerts activity towards some but not all rare BRAF substitutions. Proper…”
    Get full text
    Journal Article
  2. 2
  3. 3